TECHNETIUM TC 99M EPRATUZUMAB Uses, Dosage, Side Effects and more

TECHNETIUM TC 99M EPRATUZUMAB is under investigation in clinical trial NCT00003337 (Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma).

Trade Name TECHNETIUM TC 99M EPRATUZUMAB
Generic Technetium Tc-99m epratuzumab
Technetium Tc-99m epratuzumab Other Names TECHNETIUM TC 99M EPRATUZUMAB
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share